NEW YORK (GenomeWeb News) – Pacific Biometrics today reported that its first-quarter 2010 revenues increased 27 percent, though it also noted that it did not meet its internal revenues goal.

The Seattle-based clinical lab and biomarker assay services firm brought in total revenues of $2.3 million for the three-month period ended Sept. 30, compared to revenues of $1.8 million for the first quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.